‘This is a big deal’: Health Canada approves 1st drug to slow Alzheimer’s disease

The treatment, lecanemab, has already been approved in some other countries, including the U.S., the U.K., Japan, Mexico and China.

Leave a Reply

Your email address will not be published. Required fields are marked *